Search

Your search keyword '"Imipenem -- Health aspects"' showing total 116 results
Start Over Descriptor "Imipenem -- Health aspects"
116 results on '"Imipenem -- Health aspects"'

2. An investigation of carbapenemase-encoding genes in Burkholderia cepacia and Aeromonas sobria nosocomial infections among Iraqi patients

Subjects
Medical research -- Health aspects, Medicine, Experimental -- Health aspects, Genetic research -- Health aspects, Genes -- Health aspects, Drug resistance in microorganisms -- Health aspects, Imipenem -- Health aspects, Bacterial genetics -- Health aspects, Physical fitness -- Health aspects, Health
Abstract

2024 DEC 21 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- According to news reporting based on a preprint abstract, our journalists obtained [...]

Published
2024

4. Invasive Nocardia Infections across Distinct Geographic Regions, United States

Author

Gupta, Simran, Grant, Leah M., Powers, Harry R., Kimes, Kathryn E., Hamdi, Ahmed, Butterfield, Richard J., Gea-Banacloche, Juan, Vijayvargiya, Prakhar, Hata, D. Jane, Villegas, Diana M. Meza, Dumitrascu, Adrian C., Harris, Dana M., Chirila, Razvan M., Zhang, Nan, Razonable, Raymund R., Kusne, Shimon, Alvarez, Salvador, and Vikram, Holenarasipur R.

Subjects
United States. National Institute of Allergy and Infectious Diseases, Imipenem -- Health aspects, Infection -- Health aspects, Actinomycetales infections -- Health aspects, Health
Abstract

Nocardia is a genus of aerobic, filamentous, beaded, gram-positive bacteria ubiquitous in the environment, especially in soil, decomposing organic matter, and water. Nocardia spp. are opportunistic pathogens in immunocompromised hosts [...]

Published
2023
Full Text
View/download PDF

5. Campylobacter fetus Invasive Infections and Risks for Death, France, 2000-2021

Author

Zayet, Souheil, Klopfenstein, Timothee, Gendrin, Vincent, Vuillemenot, Jean-baptiste, Plantin, Julie, Toko, Lynda, Sreiri, Nour, and Royer, Pierre-Yves

Subjects
Ticarcillin -- Health aspects, Medical research -- Health aspects, Medicine, Experimental -- Health aspects, Imipenem -- Health aspects, Aneurysms -- Risk factors, Hospital patients -- Health aspects, Septic shock -- Risk factors, Health
Abstract

Campylobacter is a genus of microaerophilic, fastidious, gram-negative, occasionally partially anaerobic, non-spore forming, motile bacteria with a characteristic spiral or corkscrew-like appearance (1). Such morphology enables the bacteria to colonize [...]

Published
2023
Full Text
View/download PDF

6. Pseudomonas aeruginosa High-Risk Sequence Type 463 Co-Producing KPC-2 and AFM-1 Carbapenemases, China, 2020-2022

Author

Zhang, Piaopiao, Wu, Wenhao, Wang, Nanfei, Feng, Haiting, Wang, Jie, Wang, Fang, Zhang, Yan, Chen, Hongchao, Yang, Qing, Jiang, Yan, and Qu, Tingting

Subjects
Beta lactamases -- Health aspects, Imipenem -- Health aspects, Pseudomonas aeruginosa -- Health aspects, Health
Abstract

Carbapenemase-producing Pseudomonas aeruginosa poses a global threat to public health. Epidemics caused by this pathogen are associated with high-risk clones (e.g., sequence type [ST] 235, ST277, ST175, ST233 and ST111), [...]

Published
2023
Full Text
View/download PDF

7. Mycobacterium senegalense Infection in Kidney Transplant Patient with Diabetes, Memphis, Tennessee, USA

Author

Singh, Nupur, Khare, Reeti, and Mazumder, Shinn

Subjects
Kidneys -- Transplantation, Imipenem -- Health aspects, Stomach cancer -- Health aspects, Infection -- Health aspects, Diabetics -- Health aspects, Type 2 diabetes -- Health aspects, Health
Abstract

Mycobacterium senegalense, also referred to as M. conceptionense, is a nonpigmented rapid-growing mycobacterium belonging to the M. fortuitum group, which was first isolated in 2006 from a posttraumatic osteitis inflammation [...]

Published
2024

8. Case of Carbapenem-Resistant Salmonella Typhi Infection, Pakistan, 2022

Author

Nizamuddin, Summiya, Khan, Ejaz Ahmed, Chattaway, Marie Anne, and Godbole, Gauri

Subjects
Tetracycline -- Health aspects, Beta lactamases -- Health aspects, Imipenem -- Health aspects, Drug resistance -- Health aspects, Salmonella food poisoning -- Health aspects, Infection -- Health aspects, Tetracyclines -- Health aspects, Salmonella -- Health aspects, Health
Abstract

Extensively drug-resistant (XDR) Salmonella was first reported in Sindh, Pakistan, in 2016 (1). Since then, several districts have reported cases caused by multiple XDR S. enterica serovar Typhi variants belonging [...]

Published
2023
Full Text
View/download PDF

10. Vertebral osteomyelitis caused by Campylobacter jejuni in an immunocompetent patient

Author

Kirk, Karina Frahm, Boel, Jeppe, and Nielsen, Hans Linde

Subjects
Blood -- Medical examination, Osteomyelitis -- Health aspects, Gastroenteritis -- Health aspects, Imipenem -- Health aspects, Pain -- Care and treatment, Backache -- Health aspects, Abscess -- Health aspects, Health
Abstract

Background Campylobacter jejuni is the leading cause of human bacterial gastroenteritis worldwide. However, systemic infection with C. jejuni is uncommon, and osteomyelitis caused by C. jejuni is extremely rare. Cultivation from spinal bone biopsies has not previously been reported in the literature. Case presentation A 79-year-old immunocompetent male was admitted to the emergency department at Aalborg University Hospital in Denmark with lower back pain, fever and diarrhoea. A FecalSwab obtained upon admission was PCR-positive for Campylobacter spp, while an aerobic blood culture bottle was positive for C. jejuni (Time to detection: 70.4 h). A MRI of columna totalis showed osteomyelitis at L1/L2 with an epidural abscess from L1 to L2 with compression of the dura sack. The patient underwent spinal surgery with spondylodesis and decompression of L1/L2. The surgery was uncomplicated and the discus material was also culture positive for C. jejuni. The patient was treated with meropenem for a total duration of four weeks, followed by four weeks of oral treatment with clindamycin in tapered dosage. The patient recovered quickly following surgery and targeted antibiotic treatment with decreasing lumbar pain and biochemical response and was fully recovered at follow-up three months after end of treatment. Conclusions While C. jejuni osteomyelitis is rare, it should still be suspected as a possible causative bacterial aetiology in patients with vertebral osteomyelitis, in particular when symptoms of diarrhoea is involved in the clinical presentation. Susceptibility testing is crucial due to emerging resistance, and targeted treatment strategies should rely upon such tests. Keywords: Campylobacter jejuni, Vertebral osteomyelitis, Spondylodiscitis, Osteomyelitis, Bacteraemia, Gastroenteritis, Enteritis, Clindamycin, Ciprofloxacin resistance, Author(s): Karina Frahm Kirk[sup.1,2], Jeppe Boel[sup.3] and Hans Linde Nielsen[sup.2,4] Background Campylobacter spp. are microaerophilic Gram-negative bacteria with a curved or spiral shape. The genus currently consists of 44 species [...]

Published
2023
Full Text
View/download PDF

11. Findings in the Area of Cellular and Infection Microbiology Reported from Shanxi University (Activity Fingerprinting of Amr β-lactamase Towards a Fast and Accurate Diagnosis)

Subjects
Penicillin G -- Health aspects, Drug resistance in microorganisms -- Diagnosis, Imipenem -- Health aspects, Infection -- Diagnosis, Microbiology -- Health aspects, Physical fitness -- Health aspects, Health
Abstract

2023 NOV 4 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Research findings on Life Sciences - Cellular and Infection Microbiology are discussed [...]

Published
2023

12. Findings from Wayne State University Broaden Understanding of Acinetobacter baumannii (Sulbactam-durlobactam: a Novel Beta-lactam-beta-lactamase Inhibitor Combination Targeting Carbapenem-resistant Acinetobacter Baumannii Infections)

Subjects
United States. Food and Drug Administration, Beta lactamases -- Health aspects, Sulbactam -- Health aspects, Imipenem -- Health aspects, Infection -- Drug therapy, Drug approval -- Health aspects, Physical fitness -- Health aspects, Health, Wayne State University
Abstract

2023 JUL 22 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Data detailed on Gram-Negative Bacteria - Acinetobacter baumannii have been presented. According [...]

Published
2023

13. Findings from Harbin Institute of Technology Broaden Understanding of Bacterial Infections and Mycoses (Leveraging Bimetallic Nanoparticles To Synergistically Enhance the Efficacy of Antibiotics Against Carbapenem-resistant Bacteria)

Subjects
Medical research -- Health aspects, Medicine, Experimental -- Health aspects, Bacteria -- Health aspects, Drug resistance in microorganisms -- Drug therapy, Imipenem -- Health aspects, Bacterial infections -- Drug therapy, Infection -- Drug therapy, Physical fitness -- Health aspects, Health
Abstract

2023 JUL 15 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Bacterial Infections and Mycoses have been published. According [...]

Published
2023

14. Findings from Kuwait University Provide New Insights into Escherichia coli (Genomic Characteristics of an Extensive-drug-resistant Clinical escherichia Coli O99 H30 St38 Recovered From Wound)

Subjects
Urinary tract infections -- Health aspects, Drug resistance in microorganisms -- Health aspects, Imipenem -- Health aspects, Health, Kuwait University
Abstract

2024 JUL 19 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Data detailed on Gram-Negative Bacteria - Escherichia coli have been presented. According to [...]

Published
2024

16. Carbapenem Resistance Conferred by OXA-48 in K2-ST86 Hypervirulent Klebsiella pneumoniae, France

Author

Beyrouthy, Racha, Dalmasso, Guillaume, Birer, Aurelien, Robin, Frederic, and Bonnet, Richard

Subjects
Genetic aspects, Health aspects, Imipenem -- Health aspects, Virulence (Microbiology) -- Health aspects -- Genetic aspects, Oxalic acid -- Health aspects, Microbial drug resistance -- Genetic aspects, Pneumonia -- Genetic aspects, Tigecycline -- Health aspects, Meropenem -- Health aspects
Abstract

Klebsiella pneumoniae is a threat to human health because of the emergence of hypervirulent K. pneumoniae, which has caused severe community-acquired infections, and classical multidrug-resistant K. pneumoniae involved in hospital [...]

Published
2020
Full Text
View/download PDF

17. Disseminated nocardiosis with multisite involvement in an immunocompetent patient

Author

Balachandar, Arjun, Zhabokritsky, Alice, and Matukas, Larissa M.

Subjects
Health aspects, Imipenem -- Health aspects, CAT scans -- Health aspects
Abstract

A 73-year-old retired engineer presented to the emergency department with a 4-month history of transient left arm and leg paresthesias lasting minutes. His medical history included glaucoma and a 20 [...]

Published
2020
Full Text
View/download PDF

18. Death, discharge and arrhythmias among patients with COVID-19 and cardiac injury

Author

Si, Daoyuan, Du, Beibei, Ni, Lujia, Yang, Bo, Sun, Huan, Jiang, Nan, Liu, Guohui, Masse, Stephane, Jin, Lina, Nanthakumar, Jared, Bhaskaran, Abhishek, Yang, Ping, and Nanthakumar, Kumaraswamy

Subjects
Care and treatment, Health aspects, Mortality -- China, Tachycardia -- Care and treatment, Coronaviruses -- Health aspects, Imipenem -- Health aspects, Troponin -- Health aspects, Medical research -- Health aspects, Cardiac patients -- Care and treatment, COVID-19 -- Care and treatment, Meropenem -- Health aspects
Abstract

Poor outcomes have been reported recently in patients with pneumonia associated with coronavirus disease 2019 (COVID-19) and cardiac injury. (1-3) These reports did not characterize patients as dead or discharged [...], BACKGROUND: Cardiac injury is common in severe coronavirus disease 2019 (COVID-19) and is associated with poor outcomes. We aimed to study predictors of in-hospital death, characteristics of arrhythmias and the effects of QT-prolonging therapy in patients with cardiac injury. METHODS: We conducted a retrospective cohort study involving patients with severe COVID-19 who were admitted to Tongji Hospital in Wuhan, China, between Jan. 29 and Mar. 8, 2020. Among patients who had cardiac injury, which we defined as an elevated level of cardiac troponin I (cTnl), we identified demographic and clinical characteristics associated with mortality and need for invasive ventilation. RESULTS: Among 1284 patients with severe COVID-19, 1159 had a cTnl level measured on admission to hospital, of whom 170 (14.7%) had results that showed cardiac injury. We found that mortality was markedly higher in patients with cardiac injury (71.2% v. 6.6%, p < 0.001). We determined that initial cTnl (per 10-fold increase, hazard ratio [HR] 1.32, 95% confidence interval [Cl] 1.06-1.66) and peak cTnl level during illness (per 10-fold increase, HR 1.70, 95% Cl 1.38-2.10) were associated with poor survival. Peak cTnl was also associated with the need for invasive ventilation (odds ratio 3.02, 95% Cl 1.92-4.98). We found arrhythmias in 44 of the 170 patients with cardiac injury (25.9%), including 6 patients with ventricular tachycardia or fibrillation, all of whom died. We determined that patients who received QT-prolonging drugs had longer QTc intervals than those who did not receive them (difference in medians, 45 ms, p = 0.01), but such treatment was not independently associated with mortality (HR 1.04, 95% Cl 0.69-1.57). INTERPRETATION: We found that in patients with COVID-19 and cardiac injury, initial and peak cTnl levels were associated with poor survival, and peak cTnl was a predictor of need for invasive ventilation. Patients with COVID-19 warrant assessment for cardiac injury and monitoring, especially if therapy that can prolong repolarization is started. Trial registration: Chinese Clinical Trial Registry, No. ChiCTR2000031301.

Published
2020
Full Text
View/download PDF

19. 7 INFECTIOUS DISEASES

Subjects
Merck & Company Inc., Pfizer Inc., Bristol-Myers Squibb Co., Isentress (Medication) -- Health aspects, Revatio (Medication) -- Health aspects, Augmentin (Medication) -- Health aspects, Care and treatment, Health aspects, Bacterial infections -- Care and treatment -- Health aspects, Tetracyclines -- Health aspects, Imipenem -- Health aspects, Otic preparations -- Health aspects, Infection -- Care and treatment -- Health aspects, Pharmaceutical industry -- Health aspects, Gastrointestinal agents, Otitis media, Diseases, Microbiology, Respiratory system agents, Otitis, Candidiasis, Communicable diseases
Abstract

7A Bacterial infections PRESCRIBING NOTES For otic preparations for otitis media see Section 14A. For ophthalmic antiinfectives see Section 13B. For antidiarrheals see Section 5C. For vaginal candidiasis see Section [...]

Published
2020

20. Novel Subclone of Carbapenem-Resistant Klebsiella pneumoniae Sequence Type 11 with Enhanced Virulence and Transmissibility, China

Author

Zhou, Kai, Xiao, Tingting, David, Sophia, Wang, Qin, Zhou, Yanzi, Guo, Lihua, Aanensen, David, Holt, Kathryn E., Thomson, Nicholas R., Grundmann, Hajo, Shen, Ping, and Xiao, Yonghong

Subjects
Health aspects, Mortality -- China, Imipenem -- Health aspects, Pneumonia -- Health aspects, Tigecycline -- Health aspects, Phylogeny -- Health aspects, Meropenem -- Health aspects, Chinese history, Genomes, Infection
Abstract

The global dissemination of carbapenem-resistant Enterobacteriaceae (CRE) has become an urgent public health concern (1,2). In 2016, the World Health Organization included CRE in a list of antimicrobial-resistant priority pathogens [...]

Published
2020
Full Text
View/download PDF

21. Melioidosis after Hurricanes Irma and Maria, St. Thomas/St. John District, US Virgin Islands, October 2017

Author

Guendel, Irene, Ekpo, Lisa LaPlace, Hinkle, Mary K., Harrison, Cosme J., Blaney, David D., Gee, Jay E., Elrod, Mindy G., Boyd, Sandra, Gulvik, Christopher A., Liu, Lindy, Hoffmaster, Alex R., Ellis, Brett R., Hunte-Ceasar, Tai, and Ellis, Esther M.

Subjects
United States. Centers for Disease Control and Prevention, Diagnosis, Care and treatment, Health aspects, Pseudomonas infections -- Care and treatment -- Diagnosis -- Health aspects, Tetracyclines -- Health aspects, Imipenem -- Health aspects, Infection -- Care and treatment -- Diagnosis -- Health aspects, Hurricanes -- Health aspects, Methicillin -- Health aspects, Meropenem -- Health aspects, Diabetics -- Care and treatment -- Health aspects, Septicemia
Abstract

Melioidosis is caused by Burkholderia pseudomallei, a saprophytic, gram-negative bacillus endemic to tropical regions worldwide (1). Diagnosis is difficult because of wide-ranging clinical manifestations (2), and this bacterium is innately [...]

Published
2019
Full Text
View/download PDF

22. Edwardsiella tarda Bacteremia, Okayama, Japan, 2005-2016

Author

Kamiyama, Shinya, Kuriyama, Akira, and Hashimoto, Toru

Subjects
Health aspects, Tetracyclines -- Health aspects, Bacteremia -- Health aspects, Imipenem -- Health aspects, Liver diseases -- Health aspects, Blood tests -- Health aspects, Penicillin G -- Health aspects, Gastrointestinal diseases -- Health aspects, Epidemiology -- Health aspects, Liver -- Health aspects, Meropenem -- Health aspects, Cholecystitis -- Health aspects
Abstract

Edwardsiella tarda, a gram-negative, facultative anaerobe that is a member of the family Enterobacteriaceae, typically is isolated from water environments and animals that inhabit water. It is primarily associated with [...]

Published
2019
Full Text
View/download PDF

23. Novel Rapid Test for Detecting Carbapenemase

Author

Feng, Yanfang, Palanisami, Akilan, Kuriakose, Jerrin, Pigula, Michael, Ashraf, Shoaib, and Hasan, Tayyaba

Subjects
Care and treatment, Health aspects, Imipenem -- Health aspects, Beta lactamases -- Health aspects, EDTA -- Health aspects, Microbiology, Antibacterial agents, Lactams, Pneumonia, Infection, Enzymes
Abstract

As a potent [beta]-lactamase, carbapenemase can degrade almost all [beta]-lactam antimicrobial drugs, including the carbapenems, regarded as the last line of therapy for many life-threatening infections (2,2). Various epidemic types [...]

Published
2020
Full Text
View/download PDF

24. Researchers from University of Tunis El Manar Report New Studies and Findings in the Area of Urinary Tract Infections (Detection By Whole-genome Sequencing of a Novel Metallo-beta-lactamase Produced By Wautersiella Falsenii Causing Urinary ...)

Subjects
Nucleotide sequencing -- Health aspects -- Genetic aspects, Women -- Health aspects, Urinary tract infections -- Genetic aspects, Medical research -- Health aspects, Medicine, Experimental -- Health aspects, Genomics -- Genetic aspects -- Health aspects, Beta lactamases -- Genetic aspects -- Health aspects, DNA sequencing -- Health aspects -- Genetic aspects, Imipenem -- Health aspects, Ethylenediaminetetraacetic acid -- Health aspects, Health, Women's issues/gender studies
Abstract

2022 JUN 30 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Data detailed on Urologic Diseases and Conditions - Urinary Tract Infections have been presented. [...]

Published
2022

27. 7 INFECTIOUS DISEASES

Subjects
Merck & Company Inc., Pfizer Inc., Bristol-Myers Squibb Co., Isentress (Medication) -- Health aspects, Revatio (Medication) -- Health aspects, Augmentin (Medication) -- Health aspects, Care and treatment, Health aspects, Bacterial infections -- Care and treatment -- Health aspects, Tetracyclines -- Health aspects, Imipenem -- Health aspects, Otic preparations -- Health aspects, Infection -- Care and treatment -- Health aspects, Pharmaceutical industry -- Health aspects, Gastrointestinal agents, Otitis media, Diseases, Microbiology, Respiratory system agents, Otitis, Candidiasis, Communicable diseases
Abstract

7A Bacterial infections PRESCRIBING NOTES For otic preparations for otitis media see Section 14A. For ophthalmic antiinfectives see Section 13B. For antidiarrheals see Section 5C. For vaginal candidiasis see Section [...]

Published
2020

28. Understanding central nervous system efficacy of antimicrobials

Author

Tattevin, Pierre, Solomon, Tom, and Brouwer, Matthijs C.

Subjects
Cloxacillin -- Health aspects, Medical research -- Health aspects, Medicine, Experimental -- Health aspects, Tazobactam -- Health aspects, Sulbactam -- Health aspects, Imipenem -- Health aspects, Infection -- Health aspects, Zoonoses -- Health aspects, Neurosciences -- Health aspects, Health care industry
Abstract

Author(s): Pierre Tattevin [sup.1] [sup.2], Tom Solomon [sup.2] [sup.3], Matthijs C. Brouwer [sup.2] [sup.4] Author Affiliations: (1) grid.414271.5, Infectious Diseases and Intensive Care Unit, Pontchaillou University Hospital, , 2, rue [...]

Published
2019
Full Text
View/download PDF

29. 7 INFECTIOUS DISEASES

Subjects
Merck & Company Inc., Pfizer Inc., Bristol-Myers Squibb Co., Isentress (Medication) -- Health aspects, Revatio (Medication) -- Health aspects, Augmentin (Medication) -- Health aspects, Care and treatment, Health aspects, Bacterial infections -- Care and treatment -- Health aspects, Tetracyclines -- Health aspects, Imipenem -- Health aspects, Otic preparations -- Health aspects, Infection -- Care and treatment -- Health aspects, Pharmaceutical industry -- Health aspects, Gastrointestinal agents, Microbiology, Respiratory system agents, Otitis media, Otitis, Candidiasis, Communicable diseases
Abstract

7A Bacterial infections PRESCRIBING NOTES For otic preparations for otitis media see Section 14A. For ophthalmic antiinfectives see Section 13B. For antidiarrheals see Section 5C. For vaginal candidiasis see Section [...]

Published
2019

30. 7 INFECTIOUS DISEASES

Subjects
Merck & Company Inc., Pfizer Inc., Bristol-Myers Squibb Co., Isentress (Medication) -- Health aspects, Revatio (Medication) -- Health aspects, Augmentin (Medication) -- Health aspects, Care and treatment, Health aspects, Bacterial infections -- Care and treatment -- Health aspects, Tetracyclines -- Health aspects, Imipenem -- Health aspects, Otic preparations -- Health aspects, Infection -- Care and treatment -- Health aspects, Pharmaceutical industry -- Health aspects, Gastrointestinal agents, Microbiology, Respiratory system agents, Otitis media, Otitis, Candidiasis, Communicable diseases
Abstract

7A Bacterial infections PRESCRIBING NOTES For otic preparations for otitis media see Section 14A. For ophthalmic antiinfectives see Section 13B. For antidiarrheals see Section 5C. For vaginal candidiasis see Section [...]

Published
2019

31. 7 INFECTIOUS DISEASES

Subjects
Merck & Company Inc., Pfizer Inc., Bristol-Myers Squibb Co., Isentress (Medication) -- Health aspects, Revatio (Medication) -- Health aspects, Augmentin (Medication) -- Health aspects, Care and treatment, Health aspects, Bacterial infections -- Care and treatment -- Health aspects, Tetracyclines -- Health aspects, Imipenem -- Health aspects, Otic preparations -- Health aspects, Infection -- Care and treatment -- Health aspects, Pharmaceutical industry -- Health aspects, Gastrointestinal agents, Microbiology, Respiratory system agents, Otitis media, Otitis, Candidiasis, Communicable diseases
Abstract

7A Bacterial infections PRESCRIBING NOTES For otic preparations for otitis media see Section 14A. For ophthalmic antiinfectives see Section 13B. For antidiarrheals see Section 5C. For vaginal candidiasis see Section [...]

Published
2019

32. 7 INFECTIOUS DISEASES

Subjects
Merck & Company Inc., Pfizer Inc., Bristol-Myers Squibb Co., Isentress (Medication) -- Health aspects, Revatio (Medication) -- Health aspects, Augmentin (Medication) -- Health aspects, Care and treatment, Health aspects, Bacterial infections -- Care and treatment -- Health aspects, Tetracyclines -- Health aspects, Imipenem -- Health aspects, Otic preparations -- Health aspects, Infection -- Care and treatment -- Health aspects, Pharmaceutical industry -- Health aspects, Gastrointestinal agents, Microbiology, Respiratory system agents, Otitis media, Otitis, Candidiasis, Communicable diseases
Abstract

7A Bacterial infections PRESCRIBING NOTES For otic preparations for otitis media see Section 14A. For ophthalmic antiinfectives see Section 13B. For antidiarrheals see Section 5C. For vaginal candidiasis see Section [...]

Published
2019

33. 7 INFECTIOUS DISEASES

Subjects
Merck & Company Inc., Pfizer Inc., Bristol-Myers Squibb Co., Isentress (Medication) -- Health aspects, Revatio (Medication) -- Health aspects, Augmentin (Medication) -- Health aspects, Care and treatment, Health aspects, Bacterial infections -- Care and treatment -- Health aspects, Tetracyclines -- Health aspects, Imipenem -- Health aspects, Otic preparations -- Health aspects, Infection -- Care and treatment -- Health aspects, Pharmaceutical industry -- Health aspects, Gastrointestinal agents, Microbiology, Respiratory system agents, Otitis media, Otitis, Candidiasis, Communicable diseases
Abstract

7A Bacterial infections PRESCRIBING NOTES For otic preparations for otitis media see Section 14A. For ophthalmic antiinfectives see Section 13B. For antidiarrheals see Section 5C. For vaginal candidiasis see Section [...]

Published
2019

34. 7 INFECTIOUS DISEASES

Subjects
Pfizer Inc., Merck & Company Inc., Bristol-Myers Squibb Co., Augmentin (Medication) -- Health aspects, Isentress (Medication) -- Health aspects, Revatio (Medication) -- Health aspects, Viramune (Medication) -- Health aspects, Health aspects, Care and treatment, Pharmaceutical industry -- Health aspects, Infection -- Care and treatment -- Health aspects, Tetracyclines -- Health aspects, Otic preparations -- Health aspects, Bacterial infections -- Care and treatment -- Health aspects, Imipenem -- Health aspects, Communicable diseases, Candidiasis, Microbiology, Respiratory system agents, Gastrointestinal agents, Otitis, Otitis media
Abstract

7A Bacterial infections PRESCRIBING NOTES For otic preparations for otitis media see Section 14A. For ophthalmic antiinfectives see Section 13B. For antidiarrheals see Section 5C. For vaginal candidiasis see Section [...]

Published
2019

35. 7 INFECTIOUS DISEASES

Subjects
Pfizer Inc., Merck & Company Inc., Bristol-Myers Squibb Co., Augmentin (Medication) -- Health aspects, Isentress (Medication) -- Health aspects, Revatio (Medication) -- Health aspects, Health aspects, Care and treatment, Pharmaceutical industry -- Health aspects, Infection -- Care and treatment -- Health aspects, Tetracyclines -- Health aspects, Otic preparations -- Health aspects, Bacterial infections -- Care and treatment -- Health aspects, Imipenem -- Health aspects, Communicable diseases, Candidiasis, Microbiology, Respiratory system agents, Gastrointestinal agents, Otitis, Otitis media
Abstract

7A Bacterial infections PRESCRIBING NOTES For otic preparations for otitis media see Section 14A. For ophthalmic antiinfectives see Section 13B. For antidiarrheals see Section 5C. For vaginal candidiasis see Section [...]

Published
2019

36. Imipenem Resistance in Clostridium difficile Ribotype 017, Portugal

Author

Isidro, Joana, Santos, Andrea, Nunes, Alexandra, Borges, Vitor, Silva, Catarina, Vieira, Luis, Mendes, Aristides L., Serrano, Monica, Henriques, Adriano O., Gomes, Joao Paulo, and Oleastro, Monica

Subjects
Health aspects, Tetracyclines -- Health aspects, Protein binding -- Health aspects, Imipenem -- Health aspects, Infection -- Health aspects, Meropenem -- Health aspects, Tetracycline -- Health aspects
Abstract

Clostridium difficile, a toxin-producing, spore-forming bacillus, is a main cause of nosocomial antimicrobial drug-associated diarrhea in industrialized countries (1). C. difficile infection (CDI) usually develops in previously hospitalized persons with [...]

Published
2018
Full Text
View/download PDF

37. Supply Of Medicines For Medical Use: Epinephrine, Azithromycin, Allopurinol, Ambroxol, Amiodarone, Amlodipine, Ascorbic Acid, Atropine, Acetylcysteine, Diphenhydramine, Dopamine, Droperidol, Drotaverine, Imipenem + Cilastatin, Filgrastim, Losartan, Lisino

Subjects
Amiodarone -- Health aspects, Central nervous system depressants -- Health aspects, Phenols -- Health aspects, Imipenem -- Health aspects, Atropine -- Health aspects, Cardiac glycosides -- Health aspects, Vitamin C -- Health aspects, Azithromycin -- Health aspects, Epinephrine -- Health aspects, Droperidol -- Health aspects, Cardiotonic agents -- Health aspects, Acetylcysteine -- Health aspects, Amlodipine -- Health aspects, Allopurinol -- Health aspects, Business, international
Abstract

Tenders are invited for supply of medicines for medical use: epinephrine, azithromycin, allopurinol, ambroxol, amiodarone, amlodipine, ascorbic acid, atropine, acetylcysteine, diphenhydramine, dopamine, droperidol, drotaverine, imipenem + cilastatin, filgrastim, losartan, lisinopril, [...]

Published
2023

38. Supply Of Drugs For Medical Use Inn Capecitabine, Amoxicillin + Clavulanic Acid, Ampicillin + Sulbactam, Fosfomycin, Imipenem + Cilastatin, Cefuroxime (repeatedly)

Subjects
Amoxicillin -- Health aspects, Capecitabine -- Health aspects, Sulbactam -- Health aspects, Cefuroxime -- Health aspects, Imipenem -- Health aspects, Ampicillin -- Health aspects, Fosfomycin -- Health aspects, Cefuroxime axetil -- Health aspects, Business, international
Abstract

Tenders are invited for supply of drugs for medical use inn capecitabine, amoxicillin + clavulanic acid, ampicillin + sulbactam, fosfomycin, imipenem + cilastatin, cefuroxime (repeatedly) Major organization : FEDERAL STATE [...]

Published
2023

39. Supply Of A Medicinal Product For Medical Use: Imipenem + cilastatin

Subjects
Imipenem -- Health aspects, Medical supplies -- Health aspects, Business, international
Abstract

Tenders are invited for supply of a medicinal product for medical use: imipenem + cilastatin Major organization : STATE BUDGETARY INSTITUTION OF HEALTH CARE OF THE REPUBLIC OF KOMI 'UKHTA [...]

Published
2023

41. Supply Of Drugs For Medical Use Inn Capecitabine, Amoxicillin + Clavulanic Acid, Ampicillin + Sulbactam, Fosfomycin, Imipenem + Cilastatin, Cefuroxime

Subjects
Amoxicillin -- Health aspects, Capecitabine -- Health aspects, Sulbactam -- Health aspects, Cefuroxime -- Health aspects, Imipenem -- Health aspects, Ampicillin -- Health aspects, Fosfomycin -- Health aspects, Cefuroxime axetil -- Health aspects, Business, international
Abstract

Tenders are invited for supply of drugs for medical use inn capecitabine, amoxicillin + clavulanic acid, ampicillin + sulbactam, fosfomycin, imipenem + cilastatin, cefuroxime Major organization : FEDERAL STATE BUDGETARY [...]

Published
2023

43. Pulmonary Infection Associated with Mycobacterium canariasense in Suspected Tuberculosis Patient, Iran

Author

Sakhaee, Fatemeh, Vaziri, Farzam, Bahramali, Golnaz, Taremian, Kambiz, Siadat, Seyed Davar, and Fateh, Abolfazl

Subjects
Health aspects, Imipenem -- Health aspects, Lung diseases -- Health aspects, Tuberculosis -- Health aspects, Weight loss, Pathogenic microorganisms, Respiratory tract diseases, Women
Abstract

Mycobacterium tuberculosis is a widely known cause of pulmonary disease, specifically tuberculosis (TB). However, its symptoms may be similar to those of pulmonary infections caused by other pathogens. We document [...]

Published
2019

44. Assessment of bacterial pathogens and their antibiotic resistance in the air of different wards of selected teaching hospitals in Tehran

Author

Montazer, Marzieh, Soleimani, Neda, Vahabi, Masoomeh, Abtahi, Mehrnosh, Etemad, Korosh, and Zendehdel, Rezvan

Subjects
Oxacillin -- Health aspects, Drug resistance in microorganisms -- Health aspects, Imipenem -- Health aspects, Infection -- Health aspects, Pathogenic microorganisms -- Health aspects, Environmental issues, Health
Abstract

Byline: Marzieh. Montazer, Neda. Soleimani, Masoomeh. Vahabi, Mehrnosh. Abtahi, Korosh. Etemad, Rezvan. Zendehdel Context: Exposure to bio-aerosols in a variety of environments has been of great interest due to the [...]

Published
2021

47. Reports from University of Pretoria Describe Recent Advances in Beta-Lactam Antibiotics (Investigating the Need for Therapeutic Drug Monitoring of Imipenem In Critically Ill Patients: Are We Getting It Right?)

Subjects
Beta lactamases -- Health aspects, Imipenem -- Health aspects, Physical fitness -- Health aspects, Health, University of Pretoria
Abstract

2021 OCT 9 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Drugs and Therapies - Beta-Lactam Antibiotics have been [...]

Published
2021

48. NOVEL ANTIBIOTIC SUCCEEDS IN TRIAL AGAINST HOSPITAL-ACQUIRED PNEUMONIA

Subjects
United States. Food and Drug Administration, Sulbactam -- Health aspects, Imipenem -- Health aspects, News, opinion and commentary, Rutgers, The State University of New Jersey
Abstract

NEW BRUNSWICK, N.J. -- The following information was released by Rutgers University: By Andrew Smith Date May 16, 2023 A Rutgers researcher leading a trial found that the novel combination [...]

Published
2023

49. The Supply Of A Drug For Medical Use By Imipenem Cylastatin

Subjects
Imipenem -- Health aspects, Medical supplies -- Health aspects, Business, international
Abstract

Tenders are invited for the supply of a drug for medical use by imipenem cylastatin Antibacterial drugs for system use Major organization : STATE AUTONOMOUS INSTITUTION OF HEALTH 'REGIONAL CLINICAL [...]

Published
2023

50. Investigators from University of North Carolina Target Antibiotics (Treatment for Carbapenem-resistant Enterobacterales Infections: Recent Advances and Future Directions)

Subjects
Tetracycline -- Health aspects, Imipenem -- Health aspects, Tetracyclines -- Health aspects, Physical fitness -- Health aspects, Health, University of North Carolina
Abstract

2021 AUG 7 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- A new study on Drugs and Therapies - Antibiotics is now available. [...]

Published
2021

Catalog

Books, media, physical & digital resources
See catalog results